PBE
Invesco Biotechnology & Genome ETF
1W: +1.0%
1M: -4.6%
3M: -6.4%
YTD: -5.5%
1Y: +18.0%
3Y: +26.2%
5Y: +4.0%
$77.81
-0.26 (-0.33%)
After Hours: $69.90 (-7.91, -10.17%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$265M
Holdings31
Top 10 Wt48.9%
Beta1.07
% Profitable69%
Coverage100%
Portfolio Valuation
P/E22.3
P/B5.6
P/S5.4
EV/EBITDA13.5
P/FCF19.9
PEG1.06
Profitability & Returns
Gross Margin83.2%
Net Margin23.9%
ROE26.6%
ROA10.4%
ROIC18.0%
Div Yield0.51%
Leverage & Liquidity
Debt/Equity0.88
Debt/Assets0.36
Net Debt/EBITDA1.0x
Interest Cov8.2x
Current Ratio1.97
Quick Ratio1.63
Growth (YoY)
Revenue+25.3%
Net Income+82.2%
EPS+83.0%
FCF+46.1%
EBITDA+86.4%
Rev CAGR 3Y+32.4%
Quality Scores
Piotroski F6.4
Altman Z8.89
IS Quality74.5
IS Overall67.4
IS Value51.1
Median P/E19.8
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 30 | 99.9% | 29.9 |
| Financial Services | 1 | 0.1% | — |
| Other | 1 | 0.0% | — |
Smart Money Overlap
4 holdings with signals
Showing 32 of 32 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | United Therapeutics Corp | UTHR | 5.97% | $14.4M | 27,413 | 17.7 | $23.3B | Healthcare |
| 2 | Illumina Inc | ILMN | 5.53% | $13.4M | 105,610 | 22.4 | $19.0B | Healthcare |
| 3 | Gilead Sciences Inc | GILD | 5.16% | $12.4M | 87,911 | 20.0 | $169.9B | Healthcare |
| 4 | Regeneron Pharmaceuticals Inc | REGN | 5.12% | $12.4M | 16,807 | 17.3 | $78.6B | Healthcare |
| 5 | Biogen Inc | BIIB | 5.04% | $12.2M | 66,513 | 21.7 | $28.0B | Healthcare |
| 6 | Alnylam Pharmaceuticals Inc | ALNY | 5.02% | $12.1M | 38,992 | 138.3 | $43.5B | Healthcare |
| 7 | Incyte Corp | INCY | 4.94% | $11.9M | 128,445 | 14.2 | $18.4B | Healthcare |
| 8 | Amgen Inc | AMGN | 4.91% | $11.9M | 33,901 | 24.7 | $190.4B | Healthcare |
| 9 | BioCryst Pharmaceuticals Inc | BCRX | 3.77% | $9.1M | 930,299 | 7.6 | $2.0B | Healthcare |
| 10 | Protagonist Therapeutics Inc | PTGX | 3.41% | $8.2M | 81,010 | -49.9 | $6.5B | Healthcare |
| 11 | Royalty Pharma PLC | RPRX | 2.94% | $7.1M | 155,939 | 26.3 | $20.1B | Healthcare |
| 12 | TG Therapeutics Inc | TGTX | 2.91% | $7.0M | 232,043 | 10.2 | $5.1B | Healthcare |
| 13 | Neurocrine Biosciences Inc | NBIX | 2.90% | $7.0M | 54,058 | 27.5 | $13.3B | Healthcare |
| 14 | PTC Therapeutics Inc | PTCT | 2.85% | $6.9M | 102,632 | 7.9 | $5.5B | Healthcare |
| 15 | Catalyst Pharmaceuticals Inc | CPRX | 2.70% | $6.5M | 292,665 | 13.8 | $3.0B | Healthcare |
| 16 | Veracyte Inc | VCYT | 2.69% | $6.5M | 198,362 | 39.1 | $2.6B | Healthcare |
| 17 | Exelixis Inc | EXEL | 2.68% | $6.5M | 156,836 | 14.7 | $11.4B | Healthcare |
| 18 | CareDx Inc | CDNA | 2.67% | $6.5M | 367,770 | -41.8 | $899M | Healthcare |
| 19 | Halozyme Therapeutics Inc | HALO | 2.63% | $6.4M | 100,622 | 23.5 | $7.5B | Healthcare |
| 20 | Bio-Techne Corp | TECH | 2.62% | $6.3M | 122,908 | 101.3 | $8.2B | Healthcare |
| 21 | Arrowhead Pharmaceuticals Inc | ARWR | 2.62% | $6.3M | 111,193 | 42.1 | $8.5B | Healthcare |
| 22 | BioMarin Pharmaceutical Inc | BMRN | 2.57% | $6.2M | 113,057 | 30.5 | $10.7B | Healthcare |
| 23 | Repligen Corp | RGEN | 2.56% | $6.2M | 52,570 | 132.3 | $6.4B | Healthcare |
| 24 | Vericel Corp | VCEL | 2.51% | $6.1M | 185,088 | 94.4 | $1.6B | Healthcare |
| 25 | ACADIA Pharmaceuticals Inc | ACAD | 2.47% | $6.0M | 287,904 | 9.3 | $3.7B | Healthcare |
| 26 | QIAGEN NV | QIA.DE | 2.45% | $5.9M | 145,972 | 19.4 | $7.3B | Healthcare |
| 27 | Ionis Pharmaceuticals Inc | IONS | 2.44% | $5.9M | 82,849 | -31.6 | $12.3B | Healthcare |
| 28 | Collegium Pharmaceutical Inc | COLL | 2.35% | $5.7M | 156,730 | 16.9 | $1.1B | Healthcare |
| 29 | Theravance Biopharma Inc | TBPH | 2.15% | $5.2M | 371,435 | 7.3 | $776M | Healthcare |
| 30 | MannKind Corp | MNKD | 1.33% | $3.2M | 1,277,900 | 119.9 | $709M | Healthcare |
| 31 | Invesco Government & Agency Portfolio | AGPXX | 0.09% | $213,484 | 213,484 | — | $79.1B | Financial Services |
| 32 | CASH & EQUIVALENTS Cash | — | 0.00% | $5,728 | 5,728 | — | — | — |